| DRUG WATCH |
|
| Year : 2014 | Volume
: 46
| Issue : 3 | Page : 339-340 |
Spontaneous rectus sheath hematoma during rivaroxaban therapy
Ibrahim Kocayigit1, Yusuf Can2, Salih Sahinkus2, Ercan Aydin3, Mehmet Bulent Vatan2, Harun Kilic2, Huseyin Gunduz2
1 Department of Cardiology, Yenikent State Hospital, Turkey
2 Department of Cardiology, Faculty of Medicine, Sakarya University, Sakarya, Turkey
3 Department of Cardiology, Vakfikebir State Hospital, Trabzon, Turkey
Correspondence Address:
Ibrahim Kocayigit
Department of Cardiology, Yenikent State Hospital
Turkey
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0253-7613.132193
Rivaroxaban is an oral anticoagulant agent that directly inhibits Factor Xa and interrupts both the intrinsic and extrinsic pathway of the coagulation cascade and is currently indicated for use in patients for atrial fibrillation and prophylaxis of deep venous thrombosis. The present case reports of spontaneous rectus sheath hematoma during rivaroxaban therapy for atrial fibrillation in a 75-year-old woman.
[FULL TEXT] [PDF]*
|
